Search Results - Carter V
- Showing 1 - 16 results of 16
-
1
Re “Inhaled Corticosteroid Particle Size and Risk of Hospitalization Rue to Exacerbations and All-Cause Mortality in Patients With Chronic Obstructive Respiratory Disease. A... by Hubbard R, Carter V, Henley W, Price D
Published in International Journal of COPD (2025-02-01)Get full text
Article -
2
Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy by Chen S, Miravitlles M, Rhee CK, Pavord ID, Jones R, Carter V, Emmanuel B, Alacqua M, Price DB
Published in International Journal of COPD (2022-09-01)Get full text
Article -
3
Budesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population: Real-World Use and Early Medication Success by Müllerová H, Chan JSK, Heatley H, Carter V, Townend J, Skinner D, Franzén S, Marshall J, Price D
Published in International Journal of COPD (2024-05-01)Get full text
Article -
4
Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases by Smith P, Price D, Harvey R, Carney AS, Kritikos V, Bosnic-Anticevich SZ, Christian L, Skinner D, Carter V, Durieux AMS
Published in Journal of Asthma and Allergy (2017-05-01)Get full text
Article -
5
The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline by Kerkhof M, Voorham J, Dorinsky P, Cabrera C, Darken P, Kocks JWH, Sadatsafavi M, Sin DD, Carter V, Price DB
Published in International Journal of COPD (2020-08-01)Get full text
Article -
6
A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD by Tse G, Emmanuel B, Ariti C, Bafadhel M, Papi A, Carter V, Zhou J, Skinner D, Xu X, Müllerová H, Price D
Published in International Journal of COPD (2023-11-01)Get full text
Article -
7
Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation by Price DB, Yang S, Wan Yau Ming S, Hardjojo A, Cabrera C, Papaioannou AI, Loukides S, Kritikos V, Bosnic-Anticevich SZ, Carter V, Dorinsky PM
Published in International Journal of COPD (2018-12-01)Get full text
Article -
8
Data-Resource Profile: United Kingdom Optimum Patient Care Research Database by Lynam A, Curtis C, Stanley B, Heatley H, Worthington C, Roberts EJ, Price C, Carter V, Dennis J, McGovern A, Price D
Published in Pragmatic and Observational Research (2023-04-01)Get full text
Article -
9
Predicting Risk of Morbidities Associated with Oral Corticosteroid Prescription for Asthma by Stanley B, Chapaneri J, Khezrian M, Maslova E, Patel S, Gurnell M, Canonica GW, Reddel HK, Heaney LG, Bourdin A, Neil DL, Carter V, Price DB
Published in Pragmatic and Observational Research (2025-03-01)Get full text
Article -
10
Healthcare Resource Utilization Associated with Intermittent Oral Corticosteroid Prescribing Patterns in Asthma by Tran TN, Heatley H, Bourdin A, Menzies-Gow A, Jackson DJ, Maslova E, Chapaneri J, Henley W, Carter V, Chan JSK, Ariti C, Haughney J, Price D
Published in Journal of Asthma and Allergy (2024-06-01)Get full text
Article -
11
A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD by Ming SWY, Haughney J, Ryan D, Small I, Lavorini F, Papi A, Singh D, Halpin DMG, Hurst JR, Patel S, Ochel M, Kocks J, Carter V, Hardjojo A, Price DB
Published in International Journal of COPD (2020-11-01)Get full text
Article -
12
Real-World Biologic Use Patterns in Severe Asthma, 2015–2021: The CLEAR Study by Tran TN, Chen S, Emmanuel B, Altraja A, Bourdin A, Sheu CC, Tsai MJ, Hoyte FC, Quinton A, Cook B, Bulathsinhala L, Henley W, Goh CYY, Liu Y, Ariti C, Carter V, Price DB
Published in Pragmatic and Observational Research (2025-03-01)Get full text
Article -
13
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipro... by Price D, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Nudo E, Carter V, Skinner D, Vella R, Soriano JB, Kots M, Georges G
Published in Pragmatic and Observational Research (2024-01-01)Get full text
Article -
14
Preserved Ratio Impaired Spirometry in US Primary Care Patients Diagnosed with Chronic Obstructive Pulmonary Disease by Evans A, Tarabichi Y, Pace WD, Make B, Bushell N, Carter V, Chang KL, Fox C, Han MK, Kaplan A, Kocks JWH, Le Lievre C, Roussos A, Skolnik N, Soriano JB, Yawn BP, Price D
Published in Pragmatic and Observational Research (2024-12-01)Get full text
Article -
15
Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022: An Analysis of the International Severe Asthma Registry by Le TT, Price DB, Erhard C, Cook B, Quinton A, Katial R, Christoff GC, Perez-de-Llano L, Altraja A, Bergeron C, Bourdin A, Koh MS, Lehtimäki L, Mahboub B, Papadopoulos NG, Pfeffer P, Rhee CK, Carter V, Martin N, Tran TN
Published in Journal of Asthma and Allergy (2024-10-01)Get full text
Article -
16
Expert Perspectives on Next Generation Health Guidelines: How to Integrate RWE in EBM by Del Giacco S, Canonica GW, Agache I, Price D, Roche N, Schunemann H, Allan K, Ansotegui I, Barbaglia S, Bernstein JA, Bonini M, Bosnic-Anticevich S, Bousquet J, Braido F, Carter V, Chong-Neto HJ, Di Bona D, Fletton K, Gonzalez Diaz S, Ayyar Gupta V, Hubbard R, Iaccarino J, Eguiluz-Gracia I, Jacomelli C, Kocks J, Krishnan J, Mahler V, Morais-Almeida M, Moreles D, Muti P, Palkonen S, Papadopoulos NG, Pawankar R, Reeb C, Reddel H, Rojo I, Ryan D, Sodhi L, Torres M, Winders T, Wilson KC
Published in Pragmatic and Observational Research (2025-09-01)Get full text
Article
